Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hemorrhagic Disorders × Lenalidomide × Clear all

Sponsor

Conditions

Multiple Myeloma 132 Leukemia, Lymphocytic, Chronic, B-Cell 37 Lymphoma, Large B-Cell, Diffuse 23 Lymphoma, Follicular 21 Lymphoma, Non-Hodgkin 19 Lymphoma, Mantle-Cell 19 Lymphoma 19 Leukemia 19 Neoplasms, Plasma Cell 18 Recurrence 17 Myelodysplastic Syndromes 11 Lymphoma, B-Cell, Marginal Zone 11 Leukemia, Myeloid, Acute 11 Smoldering Multiple Myeloma 8 Waldenstrom Macroglobulinemia 7 Prostatic Neoplasms 7 Lymphoma, Large-Cell, Anaplastic 5 Hodgkin Disease 5 Sezary Syndrome 4 Mycosis Fungoides 4 Lymphoma, T-Cell, Peripheral 4 Lymphoma, B-Cell 4 Immunoblastic Lymphadenopathy 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Polycythemia Vera 3 Lymphoma, T-Cell, Cutaneous 3 Lymphoma, T-Cell 3 Lymphoma, Extranodal NK-T-Cell 3 Leukemia, Myelomonocytic, Chronic 3 Immunoglobulin Light-chain Amyloidosis 3

Interventions

sonidegib 1 ruxolitinib 1 Vorinostat 1 Bortezomib 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡